Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/1994
04/06/1994EP0590428A1 Azaquinoxalines, process for their preparation, and their use
04/06/1994EP0590425A1 Control of fish parasites
04/06/1994EP0590138A1 Oral treatment of helicobacter infection
04/06/1994EP0590070A1 Broad spectrum antimicrobial compounds and methods of use
04/06/1994EP0590055A1 M-protein peptides of influenza virus as antiviral agents
04/06/1994EP0590044A1 Composition and treatment with biologically active peptides having c-terminal substitutions
04/06/1994EP0590027A1 Insertional mutations in mycobacteria
04/06/1994EP0590026A1 Orally active antiviral compounds
04/06/1994EP0589995A1 Novel polypeptides and their use
04/06/1994EP0589943A1 Mycobacterium proteins and applications
04/06/1994EP0589914A1 Novel 3-fused pyridiniummethyl cephalosporins
04/06/1994EP0589886A1 Antibacterial condensed carbapenemes
04/05/1994US5300648 Dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them
04/05/1994US5300644 Reacting quinoline borate derivative with piperazine derivative, hydrolysis
04/05/1994US5300643 Viricides
04/05/1994US5300629 Bactericidal and/or bacteriostatic peptides isolated from hemolymph of honeybees
04/05/1994US5300494 Delivery systems for quaternary and related compounds
04/05/1994US5300304 Oral dosage form for controlled release up to twenty-four hours; quickly erodible polymeric coating on granules; pH sensitive
04/05/1994US5300287 Polymeric antimicrobials and their use in pharmaceutical compositions
04/05/1994CA1328258C 9-r-azacyclic erythromycin antibiotics
03/1994
03/31/1994WO1994006921A1 Recombinant retroviral vector against felv and/or fiv
03/31/1994WO1994006913A2 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
03/31/1994WO1994006912A1 Epstein-barr virus peptides and antibodies against these peptides
03/31/1994WO1994006827A1 Synthetic peptide vaccine for chlamydia trachomatis
03/31/1994WO1994006820A1 Leukinferon preparation
03/31/1994WO1994006803A1 Penem derivatives, their preparation and pharmaceutical compositions containing them
03/31/1994WO1994006775A1 5,5-disubstituted hydantoins
03/31/1994WO1994006475A1 Attenuated, live vaccine for delaware strain ibdv
03/31/1994WO1994006473A1 Restoration of immunocompetency to t helper cells in hiv infected patients
03/31/1994WO1994006471A1 Anti-feline immunodeficiency virus (fiv) vaccines
03/31/1994WO1994006470A1 Immunoreactive peptides from epstein-barr virus
03/31/1994WO1994006466A1 Therapeutic agent from mycobacterium vaccae and its use against hiv infection
03/31/1994WO1994006463A1 Immortalized cells and uses therefor
03/31/1994WO1994006454A2 Inhibitiion of retrovirus infection
03/31/1994WO1994006448A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus
03/31/1994WO1994006446A1 Hepatitis a virus vaccines
03/31/1994WO1994006431A1 Novel epoxide-containing compounds
03/31/1994WO1994006424A1 Transcutaneous in vivo activation of photosensitive agents in blood
03/31/1994WO1994006421A1 Recombinant multivalent m protein vaccine
03/31/1994WO1994006296A1 Iodine/resin disinfectant and a procedure for the preparation thereof
03/31/1994WO1994003589A3 Hepatitis a virus vaccine
03/31/1994CA2145192A1 Novel epoxide-containing compounds
03/31/1994CA2144961A1 Penem derivatives, their preparation and pharmaceutical compositions containing them
03/31/1994CA2144882A1 Synthetic peptide vaccine for chlamydia trachomatis
03/31/1994CA2144651A1 Immortalized cells and uses therefor
03/31/1994CA2144648A1 Restoration of immunocompetency to t helper cells in hiv infected patients
03/31/1994CA2142325A1 Recombinant retroviral vector against felv and/or fiv
03/31/1994CA2123584A1 Attenuated, live vaccine for delaware strain ibdv
03/30/1994EP0589428A1 Process for production of (azolylmethyl)-(biphenylmethyl)cyclopentanol derivatives
03/30/1994EP0589335A1 N1-Substituted- (1H)-1,2,3-Triazolo (4,5-d) pyrimidines, process for their preparation and their use as antiviral means
03/30/1994EP0589322A1 5-Oxo-dibenzo[a,d]cyclohepta-1,4-dienes and their use as retroviral agents
03/30/1994EP0589318A2 Antibacterial 7-(aminomethyl-oxa-7-azabicyclo(3.3.0)oct-7-yl)quinolone- and -naphthyridonecarboxylic acid derivatives
03/30/1994EP0589004A1 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
03/30/1994EP0588914A1 Eukaryotic expression vectors with regulation of rna processing
03/30/1994EP0588912A1 Blended carboxylic acid sanitizer
03/30/1994EP0588881A1 3'-end blocked oligonucleotides
03/30/1994EP0588796A1 New compounds and compositions useful as antifungal and antimycobacterial agents
03/30/1994EP0445258B1 5'-alkylphosphonylnucleosides as antivirals
03/30/1994EP0118567B1 Process for the preparationof 2-substituted cephem derivatives
03/30/1994CN1084407A Method for producing clostridium perfringens vaccines
03/29/1994US5298612 Endonucleases
03/29/1994US5298495 Partricin derivatives
03/29/1994US5298244 Proteins for immunology
03/29/1994CA2106141A1 Antibiotic compounds
03/29/1994CA1328081C2 Antibacterial antiplaque, anticalculus oral composition
03/26/1994CA2106892A1 5-oxo-dibenzo(a,d)cyclohepta-1,4-dienes
03/26/1994CA2106822A1 7-(aminomethyl-oxa-7-aza-bicyclo(3.3.0)oct-7-yl) quinolonecarboxylic and 7-(aminomethyl-oxa- 7-aza-bicyclo(3.3.0)oct-7-yl) naphthyridonecarboxylic acid derivatives
03/25/1994CA2106818A1 N1-substituted 1h-1,2,3-triazolo [4,5-d]pyrimidines, a process for their preparation and their use as antiviral agents
03/23/1994EP0588177A2 An interferon-alpha/beta binding protein, its preparation and pharmaceutical compositions containing it
03/23/1994EP0588166A2 Antibacterial 7-isoindolinyl-quinolone and naphthyridone derivatives
03/23/1994EP0588122A1 Improved antibodies to plasmodium falciparum
03/23/1994EP0587590A1 Nerve growth factor for use in the prevention and treatment of viral infections
03/23/1994CN1084178A 2'-deoxy-2'-2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates
03/23/1994CN1084177A 2'-deoxy-2',2'-difluoro(4-substituted pyrimidine) nucleosides having anti-viral and anti-cancer activity and intermediates
03/23/1994CN1084175A Novel phospholipid derivatives
03/23/1994CN1084173A 1-AzabicycloÛ3.2.0Ùhept-2-ene-2-carboxylic acid derivatives and their preparation
03/23/1994CN1084010A Treatment of diseas of shrimp
03/22/1994US5296597 Antibiotics
03/22/1994US5296503 Medicaments containing substituted 2-cyclohexene derivatives and their use for the control of candida infections
03/17/1994WO1994005813A1 Compositions and methods for treatment of hepatitis c virus-associated diseases
03/17/1994WO1994005792A1 Self-assembling recombinant papillomavirus capsid proteins
03/17/1994WO1994005700A2 Methods and reagents to detect and characterize norwalk and related viruses
03/17/1994WO1994005687A1 Antiviral pyrimidine nucleosides
03/17/1994WO1994005683A1 Rokitamycin monohydrate crystal and process for producing the same
03/17/1994WO1994005669A1 Cationic-2-heteroarylphenyl-carbapenem antibacterial agents
03/17/1994WO1994005667A1 Carbapenem derivatives and processes for preparing the same
03/17/1994WO1994005666A1 Condensed carbapenem derivatives
03/17/1994WO1994005649A1 4-hydroxy coumarin derivatives with antibacterial activity
03/17/1994WO1994005639A1 Sulfonamide inhibitors of hiv-aspartyl protease
03/17/1994WO1994005635A1 Anti-viral sulfur-analogues of 1,5-dideoxy-1,5-imino-d-glucitol (deoxynojirimycin)
03/17/1994WO1994005632A1 4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use
03/17/1994WO1994005327A1 New hiv-1 isolates of a subtype and its differential diagnosis, vaccine against hiv-1 infection of this subtype and process for preparing and using the hiv-1 isolate
03/17/1994WO1994005325A1 Vaccines against group c neisseria meningitidis
03/17/1994WO1994005285A1 Metallo porphyrin compositions
03/17/1994WO1994005263A1 Beads having a core coated with an antifungal and a polymer
03/17/1994WO1994005203A1 Biocompatible polymers containing diagnostic or therapeutic moieties
03/17/1994WO1993025682A3 Chimeric receptor polypeptides, human h13 proteins and uses thereof
03/17/1994WO1993018055A3 Peptides stimulating cytotoxic lymphocytes respone to hiv-1 gp160
03/17/1994WO1993017020A3 Therapeutic nucleosides
03/17/1994CA2143834A1 Antiviral pyrimidine nucleosides